SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-003558
Filing Date
2024-01-16
Accepted
2024-01-16 09:26:37
Documents
13
Period of Report
2024-01-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea191615-6k_clearmind.htm 6-K 23071
2 OPINION OF DANIEL N. BLOCH, CANADIAN COUNSEL TO THE REGISTRANT ea191615ex5-1_clearmind.htm EX-5.1 21374
3 OPINION OF GREENBERG TRAURIG, P.A., U.S. COUNSEL TO THE REGISTRANT ea191615ex5-2_clearmind.htm EX-5.2 13384
4 SECURITIES PURCHASE AGREEMENT ea191615ex10-1_clearmind.htm EX-10.1 256148
5 FORM OF PIPE COMMON WARRANTS ea191615ex10-2_clearmind.htm EX-10.2 130729
6 FORM OF REGISTERED PREFUNDED WARRANTS ea191615ex10-3_clearmind.htm EX-10.3 105568
7 REGISTRATION RIGHTS AGREEMENT ea191615ex10-4_clearmind.htm EX-10.4 158587
8 PLACEMENT AGENT AGREEMENT ea191615ex10-5_clearmind.htm EX-10.5 75534
9 GRAPHIC ex5-1_001.jpg GRAPHIC 3031
10 GRAPHIC ex5-1_002.jpg GRAPHIC 1376
11 GRAPHIC ex5-2_001.jpg GRAPHIC 3215
12 GRAPHIC ex10-5_001.jpg GRAPHIC 12733
13 GRAPHIC ex10-5_002.jpg GRAPHIC 1708
  Complete submission text file 0001213900-24-003558.txt   816558
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 24533889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)